Galbinothrix, a new monotypic genus of Chrysotrichaceae (Arthoniomycetes) lacking pulvinic acid derivatives
Plant and Fungal Systematics · 2018
DOI: 10.2478/pfs-2018-0005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Plant and Fungal Systematics, 2018. Verfasst von Andreas Frisch und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 3.0).
Abstract (Originalsprache)
Galbinothrix caesiopruinosa is described from Japan and Korea. The new genus and species is placed in Chrysotrichaceae by its ascoma morphology and by a phylogenetic analysis of mtSSU and nLSU sequence data using Bayesian and maximum likelihood inference. The monotypic genus Galbinothrix is superficially similar to Chrysothrix caesia in having dark brown ascomata covered by a thin bluish grey pruina, reddish brown ascomatal pigment in the epithecium and proper exciple, the greyish green to yellowish olive thallus, and usnic acid as the main secondary thallus compound. It differs from this species and all other Chrysotrichaceae by its large, oblong, thick-walled ascospores with a distinct epispore, the narrowly clavate to almost tubular asci, and the never clearly granular to leprose thallus.
Zitieren
APA
Frisch, A., Thor, G., Moon, K. H., & Ohmura, Y. (2018). Galbinothrix, a new monotypic genus of Chrysotrichaceae (Arthoniomycetes) lacking pulvinic acid derivatives. Plant and Fungal Systematics. https://doi.org/10.2478/pfs-2018-0005
Vancouver
Frisch A, Thor G, Moon KH, Ohmura Y. Galbinothrix, a new monotypic genus of Chrysotrichaceae (Arthoniomycetes) lacking pulvinic acid derivatives. Plant and Fungal Systematics. 2018. doi:10.2478/pfs-2018-0005
BibTeX
@article{Frisch2018,
author = {Frisch, Andreas and Thor, Göran and Moon, Kwang Hee and Ohmura, Yoshihito},
title = {Galbinothrix, a new monotypic genus of Chrysotrichaceae (Arthoniomycetes) lacking pulvinic acid derivatives},
journal = {Plant and Fungal Systematics},
year = {2018},
doi = {10.2478/pfs-2018-0005}
}
EUVIMED